The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation have awarded a $410,000 grant to fund research based on a new method for treating cognitive ... Read more
A study of Iranian patients with early-onset multiple sclerosis (MS) found women to be in the majority, optic neuritis to be the most common first disease symptom, and relapsing-remitting ... Read more
An association between high blood pressure and reduction of brain integrity in multiple sclerosis (MS) patients highlights the importance of blood pressure management by MS healthcare providers. The severity ... Read more
Treatment with Gilenya (fingolimod) is associated with treatment satisfaction, which, in turn, is linked to a better quality-of-life in patients with relapsing-remitting multiple sclerosis (RRMS), a study has found. Gilenya, ... Read more
Oral steroids may be cheaper, more convenient and less invasive alternatives than intravenous steroids in treating relapses in multiple sclerosis (MS) patients, suggests an analysis of five randomized trials. ... Read more
Nearly half of multiple sclerosis patients do not always report their relapses to healthcare providers, two surveys indicate. Mallinckrodt sponsored the surveys to better understand patients’ experience with relapses, which are sudden ... Read more
Most multiple sclerosis patients who try Bayer’s BETACONNECT auto-injector stick with their treatment, a study reports.
The electronic product may overcome the problem of many patients failing to stick to a therapy ... Read more